FDA antidepressant warnings: Use caution when starting medication
The
Food and Drug Administration (FDA) sometimes releases warnings on
medications when a medication previously approved is shown to be
potentially harmful. It's possible for new side effects and other
problems to come up after medications are approved and been on the
market for awhile. Once a warning is issued (if the medication is not
removed from the market), close monitoring continues. Why am I writing
about this subject? In 2004, a warning was issued regarding
antidepressant medication use in children and adolescents. This warning
was later expanded to include young adults (ages 18 to 24). There was
concern that antidepressants might increase the risk of suicide in
these age groups (this risk was not found in those older than 24).
The FDA specifically advised:
* Anyone who starts being treated with antidepressant medicines,
particularly those being treated for depression, should be watched
closely for worsening of depression and for increased suicidal thinking
or behavior.
* Close observation of adults may be especially
important when antidepressant medications are started for the first
time or when doses for their antidepressant medications have been
changed.
* Adults whose symptoms worsen while being treated with
antidepressants, including an increase in suicidal thinking or
behavior, should be evaluated by their health care professional.
Please
take the time to review potential side effects with your health care
provider. It's important that you are well informed about both your
illness and treatment options, including risks, benefits and
alternatives.
By Mayo Clinic Staff
Jan. 17, 2009
© 1998-2009 Mayo Foundation for Medical Education and Research (MFMER)